Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients

被引:54
|
作者
Obling, Laust [1 ]
Frydland, Martin [1 ]
Hansen, Rikke [2 ]
Moller-Helgestad, Ole Kristian [2 ]
Lindholm, Matias Greve [1 ]
Holmvang, Lene [1 ]
Ravn, Hanne Berg [3 ]
Wiberg, Sebastian [1 ]
Thomsen, Jakob Hartvig [1 ]
Jensen, Lisette Okkels [2 ]
Kjaergaard, Jesper [1 ]
Moller, Jacob Eifer [2 ]
Hassager, Christian [1 ]
机构
[1] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark
[2] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[3] Rigshosp, Copenhagen Univ Hosp, Dept Thorac Anesthesiol, Ctr Heart, Copenhagen, Denmark
关键词
Cardiogenic shock; STEMI; prediction; mortality; prognosis; PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; EARLY REVASCULARIZATION; PCI REGISTRY; TRENDS; MANAGEMENT; OUTCOMES; INDEX; PREDICTOR; PROGNOSIS;
D O I
10.1177/2048872617706503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The incidence of cardiogenic shock (CS) in patients with ST-segment elevation myocardial infarction (STEMI) is as high as 10%. The majority of patients are thought to develop CS after admission (late CS), but the incidence in a contemporary STEMI cohort admitted for primary percutaneous intervention remains unknown. Aim: The aim of this study was to assess the incidence and time of CS onset in patients with suspected STEMI admitted in two high-volume tertiary heart centres and to assess the variables associated with the development of late CS. Methods: We included consecutive patients admitted for acute coronary angiography with suspected STEMI in a 1-year period. Cardiogenic shock was based on clinical criteria and subdivided into patients with shock on admission, patients developing shock during catheterisation and patients developing shock later during hospitalisation. Follow-up for all-cause mortality was done using registries. Results: A total of 2247 patients with suspected STEMI were included, whereof 225 (10%) developed CS. The majority (56%) had CS on admission, 16% developed CS in the catheterisation laboratory and 28% developed late CS. Thirty-day mortality was 3.1% versus 47% in non-CS versus CS patients (p(logrank) < 0.0001). Age, stroke, time from symptom onset to intervention, anterior STEMI, heart rate/systolic blood pressure ratio and being comatose after resuscitation from cardiac arrest were independently associated with the development of late CS. Conclusion: In this study, 10% of patients admitted with suspected STEMI for acute coronary angiography presented with or developed CS. Most were in shock on admission. Irrespective of the timing of shock, mortality was high.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 50 条
  • [41] Prognostic Utility of Culprit SYNTAX Score in Patients With Cardiogenic Shock Complicating ST-Segment Elevation Myocardial Infarction
    Kim, Kyehwan
    Kang, Min Gyu
    Park, Hyun Woong
    Koh, Jin-Sin
    Park, Jeong-Rang
    Hwang, Seok-Jae
    Hwang, Jin-Yong
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 154 : 14 - 21
  • [42] ST-segment elevation in baseline electrocardiogram predicts mortality in cardiogenic shock
    Javanainen, T.
    Tolppanen, H. E. V.
    Harjola, V. P.
    Lassus, J.
    Tarvasmaki, T.
    Nieminen, M. S.
    Spinar, J.
    Sionis, A.
    Banaszewski, M.
    Jurkko, R.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 216 - 217
  • [43] Prognostic factors in young patients with ST-segment elevation myocardial infarction
    Zhang, Zhanshuai
    Qin, Shaoqiang
    Wang, Rui
    Wang, Yaling
    Fang, Zhiqin
    [J]. CORONARY ARTERY DISEASE, 2023, 34 (05) : 298 - 305
  • [44] Bleeding risk in ST-segment elevation myocardial infarction
    Benamer, H.
    Meftout, B.
    Chevalier, B.
    [J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 (06): : 356 - 361
  • [45] Risk Scores in ST-Segment Elevation Myocardial Infarction Patients with Refractory Cardiogenic Shock and Veno-Arterial Extracorporeal Membrane Oxygenation
    Semaan, Carl
    Charbonnier, Arthur
    Pasco, Jeremy
    Darwiche, Walid
    Saint Etienne, Christophe
    Bailleul, Xavier
    Bourguignon, Thierry
    Fauchier, Laurent
    Angoulvant, Denis
    Ivanes, Fabrice
    Genet, Thibaud
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 14
  • [46] ST-segment elevation myocardial infarction
    Yerem Yeghiazarians
    Peter H. Stone
    [J]. Current Treatment Options in Cardiovascular Medicine, 2002, 4 (1) : 3 - 23
  • [47] Independent Predictors of Late Presentation in Patients with ST-Segment Elevation Myocardial Infarction
    Rodrigues, Juliane Araujo
    Melleu, Karina
    Schmidt, Marcia Moura
    Mascia Gottschall, Carlos Antonio
    Pereira de Moraes, Maria Antonieta
    de Quadros, Alexandre Schaan
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 111 (04) : 587 - 593
  • [48] ST-segment elevation myocardial infarction
    Birgit Vogel
    Bimmer E. Claessen
    Suzanne V. Arnold
    Danny Chan
    David J. Cohen
    Evangelos Giannitsis
    C. Michael Gibson
    Shinya Goto
    Hugo A. Katus
    Mathieu Kerneis
    Takeshi Kimura
    Vijay Kunadian
    Duane S. Pinto
    Hiroki Shiomi
    John A. Spertus
    P. Gabriel Steg
    Roxana Mehran
    [J]. Nature Reviews Disease Primers, 5
  • [49] ST-Segment Elevation Acute Myocardial Infarction Complicated by Cardiogenic Shock: Early Predictors of Very Long-Term Mortality
    Cosentino, Nicola
    Resta, Marta L.
    Somaschini, Alberto
    Campodonico, Jeness
    D'Aleo, Giampaolo
    Di Stefano, Giovanni
    Lucci, Claudia
    Moltrasio, Marco
    Bonomi, Alice
    Cornara, Stefano
    Demarchi, Andrea
    De Ferrari, Gaetano
    Bartorelli, Antonio L.
    Marenzi, Giancarlo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [50] ST-segment elevation myocardial infarction
    Vogel, Birgit
    Claessen, Bimmer E.
    Arnold, Suzanne, V
    Chan, Danny
    Cohen, David J.
    Giannitsis, Evangelos
    Gibson, C. Michael
    Coto, Shinya
    Katus, Hugo A.
    Kerneis, Mathieu
    Kimura, Takeshi
    Kunadian, Vijay
    Pinto, Duane S.
    Shiomi, Hiroki
    Spertus, John A.
    Steg, P. Gabriel
    Mehran, Roxana
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)